A bioinformatics company with a focus on biomarker discovery has received seed funding from two UK venture funds in order to carry out its work identifying markers suitable for helping investigators select patients for clinical trials. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
